ALLO
Allogene Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD2.00
-0.05 (-2.44%)
Rating:C-
Company Profile
CEO
David D. Chang
IPO Date
2018-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$2.07
Prev. Close
$2.05
Day Low
$1.96
Day High
$2.07
52W Low
$0.98
52W High
$4.46
Market Cap
$0.49B
Volume
9.04M